Please login to the form below

Not currently logged in
Email:
Password:

Creative directors join The Prime Medical Group’s UK offices

Adam Moriarty and Craig Armstrong join London and Cheshire teams

The Prime Medical Group Craig ArmstrongMedical education and communications firm The Prime Medical Group has appointed two new creative directors to its UK offices.

Adam Moriarty becomes senior creative designer of the group's London office, bringing over 20 years of creative and technical experience within the education, entertainment, media and pharmaceutical sectors.

Moriarty has worked with a number of agencies including Chameleon, Echo Group and Medaxial, and specialises in graphics and photography.

Meanwhile, Craig Armstrong (pictured above) joins The Prime Medical Group's Knutsford office in Cheshire.

Armstrong takes up the role of creative director, joining with over 20 years of experience in the healthcare and retail industries.

The group's managing director Graeme Peterson said: “It's an exciting time for the group; we are fortunate to have two industry-leading creatives joining the team and supporting our vision.

“This new focus on design and creativity, combined with the exceptional calibre of scientific expertise already in the business, it is already shining through.

“Both Craig and Adam bring a wealth of experience to the business. I welcome them both to the group and wish them luck in their new roles.”

9th May 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics